Client industries · November 2026
Bring the Role to the Lawyer: Medical Device Lawyers Rarely Relocate
Lawyers with a medical device focus change city on far fewer of their moves than the rest of the market, over one year and over three. Most of those who move are partners, with litigation, patent and health care practices, so a device company has to recruit where they already work, starting in Washington.
The short version
- 12.6% of lateral moves by medical device lawyers came with a change of city, against 20.5% across the market.
- Over 36 months, device-focused lawyers changed city on 16.9% of their moves, against 21.6% market-wide.
- Washington took 15.6% of device-focused lateral arrivals, an index of 278 against its market share.
- Partners were 63.3% of medical device lawyers who changed firms, against 27.7% of all lateral moves.
- Health care appears in device-focused lateral moves at an index of 841 against the market.
The analysis
Anyone hiring in-house counsel at a medical device company should build the search around one habit of this bench: its lawyers rarely change city. Sartori & Partners data show that 12.6% of lateral moves by lawyers with a medical device focus came with a new city in the 12 months to October 2026, against 20.5% across all lateral moves. In every other move the lawyer changed firm without changing address. The figures come from public law-firm announcements, firm websites and professional profiles, checked monthly, and count only moves where both the old and the new city are known. This report sets that low mobility against the market and the neighboring health sectors, shows where the bench sits, who is in it, and what a device company should do about it.
- 12.6%
- of device-focused moves changed city
- 20.5%
- of all lateral moves changed city
- 18.4%
- of pharma and biotech moves changed city
Device lawyers relocate far less often than the market and their neighbors
The gap is wide. Device-focused lawyers changed city on 12.6% of their moves, 7.9 points below the market rate of 20.5%. Read the other way, a lawyer in the wider market relocates 1.6 times as often as a device lawyer. The closest sectors behave much more like the market. Lawyers with a pharma and biotech focus changed city on 18.4% of their moves, and those focused on healthcare providers and payors on 19.2%.
So the reluctance belongs to devices, not to life sciences or health work in general. For a company the consequence is practical. A role based in a city where few device lawyers practice starts at a disadvantage, because the people most able to fill it have shown, move after move, that they prefer to stay where they are.
Three years of moves tell the same story
This is not one quiet year. Across the 36 months to October 2026, 16.9% of device-focused moves came with a new city, against 21.6% for the whole market over the same window. The longer record rests on 498 moves. Pharma and biotech lawyers changed city on 18.3% of their moves over those 36 months, and healthcare providers and payors lawyers on 21.8%.
The latest year is the most settled of all. The 12-month device share of 12.6% sits under the 36-month share of 16.9%, while the market's two figures stay close, at 20.5% and 21.6%. Volume did not change the picture either: device-focused moves held flat (+13.9%) year on year in the settled windows, 180 against 158, while all lateral moves rose 9.0%. A steady count of moves is not a shrinking bench, since many device lawyers never change firms and can still be approached. The point for a hiring company is that waiting will not bring a more mobile pool.
Washington holds the bench, at 278 on the market index
If the bench does not travel, the question becomes where it sits. In the Sartori & Partners lateral database, Washington took 15.6% of device-focused arrivals in the past 12 months, against 5.6% of all lateral arrivals, an index of 278. New York, the largest legal market, took 13.9% of device moves, an index of 94, a little under its market weight. Washington is also where many of these moves start: it was the city left on 13.9% of device moves.
| City | Device focus | All lateral moves |
|---|---|---|
| Washington, DC | 16.1% | 5.2% |
| New York | 13.3% | 14.2% |
| Boston | 7.6% | 2.3% |
| Los Angeles | 6.6% | 4.8% |
| Chicago | 4.8% | 4.0% |
| San Francisco | 4.6% | 2.8% |
The 36-month map adds a second cluster. Over that window Washington took 16.1% of device-focused arrivals against 5.2% for the market, and Boston 7.6% against 2.3%. The federal agencies that clear devices and oversee their marketing sit in and around the capital, and Boston carries a deep life sciences base. Companies already draw on Washington: among lawyers who left law firms for companies in any sector between May and October 2026, 7.3% left from Washington, against 16.1% from New York. A device search should therefore open in Washington, extend to Boston and New York, and treat any other city as a relocation case to be priced from the start.
A senior bench: partners are 63.3% of device movers
Seniority helps explain the stillness. Partners were 63.3% of device-focused lateral moves in the past 12 months, 2.3 times their 27.7% share across the market, while associates were 21.1% against 58.5%. Over 36 months partners made up 60.6% of device moves, against 26.9%, so the senior tilt is constant. A partner with a device practice usually carries clients and agency contacts built in one city, which fits a bench that changes firm but keeps its address.
| Level | Device focus | All lateral moves |
|---|---|---|
| partner | 63.3% | 27.7% |
| counsel | 15.0% | 12.7% |
| associate | 21.1% | 58.5% |
Firms also reward the move with a title more often here: 17.2% of device-focused movers joined at a higher title, against 12.9% market-wide. Companies, by contrast, hire juniors out of firms: across all sectors, associates were 76.7% of the 953 lawyers who joined a company from a law firm between May and October 2026, and partners 11.0%. A device company that wants a senior lawyer is asking a partner to give up a local practice and a firm ready to promote; one that wants a junior is fishing in a narrow associate flow. Either way, the offer has to work in the lawyer's own city.
| Rank | Firm | Band |
|---|---|---|
| 1 | Greenberg Traurig | 11-20 |
| 2 | Barnes & Thornburg | 11-20 |
| 3 | Alston & Bird | 6-10 |
| 4 | Bowman and Brooke | 6-10 |
| 5 | Faegre Drinker Biddle & Reath | 6-10 |
| 6 | McDermott Will & Schulte | 6-10 |
| 7 | Merchant & Gould | 6-10 |
| 8 | Morrison & Foerster | 6-10 |
| 9 | Morgan, Lewis & Bockius | 6-10 |
| 10 | Kirkland & Ellis | 6-10 |
Health care and patent work run far above their market weight
Sartori & Partners records of the practices on these moves show why the bench is rooted. Health care appears in 25.0% of device-focused moves, an index of 841 against its share of all lateral moves. Intellectual property runs at an index of 645 and product liability and torts at 261. Litigation is the largest single practice, at 49.4% of moves and an index of 124, while corporate and M&A sits below the market at 73. One lawyer can carry several practices, so the shares overlap.
Partners show the same profile, with health care partners at an index of 699 and patent partners at 515. Each of these practices ties a lawyer to a place: regulatory work to the agencies, patent work to the courts and the patent office, product cases to the venues where they are tried. Write the in-house role around the work it will do. A regulatory lead, a patent lead and a product litigation lead are three separate searches, and each should begin with the lawyers already practicing where the company needs them.
What this means for device companies hiring in-house
Recruit where the lawyer already works. With 12.6% of device-focused moves crossing a city line, against 20.5% market-wide, a relocation clause is the weakest part of any offer to this group. Open in Washington, which took 15.6% of device-focused arrivals, then Boston and New York.
Place the role, not the person. A company whose head office sits elsewhere can base its regulatory or patent counsel in Washington or Boston, or agree a hybrid pattern, rather than ask a settled partner to move house. Price senior offers against partner earnings, since partners are 63.3% of device movers. For a junior seat, accept candidates from general litigation or product liability who can learn the device rules on the job, because device-focused associates are only 21.1% of the flow. Map the firms in the list above as the places these lawyers already sit.
Questions readers ask
What should I expect when hiring in-house counsel at a medical device company?
Expect a local search: only 12.6% of lateral moves by device-focused lawyers changed city, against 20.5% across the market. Start in Washington, then look in Boston and New York, and base the role there if the head office is elsewhere.
Do medical device lawyers relocate for a new job?
Rarely: 12.6% of their lateral moves came with a new city over 12 months and 16.9% over 36 months. The market figures for the same windows are 20.5% and 21.6%.
Where do medical device lawyers work?
Washington first: it took 15.6% of device-focused arrivals in 12 months, an index of 278 against its share of all lateral moves. Over 36 months New York and Boston follow.
Which practices do medical device lawyers carry?
Litigation is the largest, at 49.4% of device-focused moves, but health care runs furthest above the market, at an index of 841. Intellectual property follows at an index of 645.
Where this comes from
The monitor behind this report
Related reports
Working with us
Edition November 2026. Window: November 2025 to October 2026.
Edition November 2026. Window: November 2025 to October 2026. Source: Sartori & Partners, from public law-firm announcements, firm websites and professional profiles, checked monthly. Methodology. Spot an error? [email protected].
For general counsel and boards
Hiring a lawyer in-house?
A retained search starts with the market: who could take the role, where they sit and what it will take to move them.